Literature DB >> 10096878

Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.

P Pollesello1, A Annila, M Ovaska.   

Abstract

The structure of a 36-amino-acid-long amino-terminal fragment of phospholamban (phospholamban[1-36]) in aqueous solution containing 30% trifluoroethanol was determined by nuclear magnetic resonance. The peptide, which comprises the cytoplasmic domain and six residues of the transmembrane domain of phospholamban, assumes a conformation characterized by two alpha-helices connected by a turn. The residues of the turn are Ile18, Glu19, Met20, and Pro21, which are adjacent to the two phosphorylation sites Ser16 and Thr17. The proline is in a trans conformation. The helix comprising amino acids 22-36 is well determined (the root mean square deviation for the backbone atoms, calculated for a family of 18 nuclear magnetic resonance structures is 0.57 A). Recently, two molecular models of the transmembrane domain of phospholamban were proposed in which a symmetric homopentamer is composed of a left-handed coiled coil of alpha-helices. The two models differ by the relative orientation of the helices. The model proposed by,Simmerman et al. (H.K. Simmerman, Y.M. Kobayashi, J.M. Autry, and L.R. Jones, 1996, J. Biol. Chem. 271:5941-5946), in which the coiled coil is stabilized by a leucine-isoleucine zipper, is similar to the transmembrane pentamer structure of the cartilage oligomeric membrane protein determined recently by x-ray (V. Malashkevich, R. Kammerer, V Efimov, T. Schulthess, and J. Engel, 1996, Science 274:761-765). In the model proposed by Adams et al. (P.D. Adams, I.T. Arkin, D.M. Engelman, and A.T. Brunger, 1995, Nature Struct. Biol. 2:154-162), the helices in the coiled coil have a different relative orientation, i.e., are rotated clockwise by approximately 50 degrees. It was possible to overlap and connect the structure of phospholamban[1-36] derived in the present study to the two transmembrane pentamer models proposed. In this way two models of the whole phospholamban in its pentameric form were generated. When our structure was connected to the leucine-isoleucine zipper model, the inner side of the cytoplasmic domain of the pentamer (where the helices face one another) was lined by polar residues (Gln23, Gln26, and Asn30), whereas the five Arg25 side chains were on the outer side. On the contrary, when our structure was connected to the other transmembrane model, in the inner side of the cytoplasmic domain of the pentamer, the five Arg25 residues formed a highly charged cluster.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10096878      PMCID: PMC1300156          DOI: 10.1016/S0006-3495(99)77339-X

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  61 in total

1.  The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy.

Authors:  D S Wishart; B D Sykes; F M Richards
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

2.  Simple techniques for the quantification of protein secondary structure by 1H NMR spectroscopy.

Authors:  D S Wishart; B D Sykes; F M Richards
Journal:  FEBS Lett       Date:  1991-11-18       Impact factor: 4.124

Review 3.  Regulation of the Ca2+ pump ATPase by cAMP-dependent phosphorylation of phospholamban.

Authors:  M Tada; M Kadoma
Journal:  Bioessays       Date:  1989-05       Impact factor: 4.345

4.  Expression and site-specific mutagenesis of phospholamban. Studies of residues involved in phosphorylation and pentamer formation.

Authors:  J Fujii; K Maruyama; M Tada; D H MacLennan
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

5.  Cysteine reactivity and oligomeric structures of phospholamban and its mutants.

Authors:  C B Karim; J D Stamm; J Karim; L R Jones; D D Thomas
Journal:  Biochemistry       Date:  1998-09-01       Impact factor: 3.162

6.  Complete assignment of the 1H nuclear magnetic resonance spectrum of French bean plastocyanin. Application of an integrated approach to spin system identification in proteins.

Authors:  W J Chazin; M Rance; P E Wright
Journal:  J Mol Biol       Date:  1988-08-05       Impact factor: 5.469

7.  Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. Effects of synthetic phospholamban peptides on Ca2+ pump ATPase.

Authors:  T Sasaki; M Inui; Y Kimura; T Kuzuya; M Tada
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

8.  Regulation of the calcium ion pump of sarcoplasmic reticulum: reversible inhibition by phospholamban and by the calmodulin binding domain of the plasma membrane calcium ion pump.

Authors:  T Vorherr; M Chiesi; R Schwaller; E Carafoli
Journal:  Biochemistry       Date:  1992-01-21       Impact factor: 3.162

9.  Folding of peptide fragments comprising the complete sequence of proteins. Models for initiation of protein folding. I. Myohemerythrin.

Authors:  H J Dyson; G Merutka; J P Waltho; R A Lerner; P E Wright
Journal:  J Mol Biol       Date:  1992-08-05       Impact factor: 5.469

10.  Secondary structure of detergent-solubilized phospholamban, a phosphorylatable, oligomeric protein of cardiac sarcoplasmic reticulum.

Authors:  H K Simmerman; D E Lovelace; L R Jones
Journal:  Biochim Biophys Acta       Date:  1989-08-31
View more
  13 in total

1.  Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.

Authors:  M Asahi; N M Green; K Kurzydlowski; M Tada; D H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy.

Authors:  H S Young; L R Jones; D L Stokes
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

3.  Structure of the 1-36 N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17.

Authors:  Piero Pollesello; Arto Annila
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

4.  NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles.

Authors:  Jamillah Zamoon; Alessandro Mascioni; David D Thomas; Gianluigi Veglia
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

5.  The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.

Authors:  M Germana Paterlini; David D Thomas
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

6.  Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells.

Authors:  Eileen M Kelly; Zhanjia Hou; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

7.  Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers.

Authors:  Deo R Singh; Michael P Dalton; Ellen E Cho; Marsha P Pribadi; Taylor J Zak; Jaroslava Šeflová; Catherine A Makarewich; Eric N Olson; Seth L Robia
Journal:  J Mol Biol       Date:  2019-08-23       Impact factor: 5.469

8.  Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump.

Authors:  John Paul Glaves; Catharine A Trieber; Delaine K Ceholski; David L Stokes; Howard S Young
Journal:  J Mol Biol       Date:  2010-11-23       Impact factor: 5.469

9.  Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone.

Authors:  Christine B Karim; Tara L Kirby; Zhiwen Zhang; Yuri Nesmelov; David D Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-24       Impact factor: 11.205

10.  The anti-apoptotic protein HAX-1 is a regulator of cardiac function.

Authors:  Wen Zhao; Jason R Waggoner; Zhi-Guo Zhang; Chi Keung Lam; Peidong Han; Jiang Qian; Paul M Schroder; Bryan Mitton; Aikaterini Kontrogianni-Konstantopoulos; Seth L Robia; Evangelia G Kranias
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.